4/12/2021 11:00:13 AM
Akari Therapeutics Initiates Pivotal Phase III Trial Of Nomacopan In Bullous Pemphigo
10/6/2020 8:38:59 AM
Akari Announces Further Progress In COVID-19 Pneumonia Program With Nomacopan In US, Brazil
9/29/2020 11:10:19 AM
Akari Therapeutics To Present Its Phase III Plans At IPPF Patient Education Conference
9/1/2020 8:39:01 AM
Akari Therapeutics Q2 Net Loss $8.3 Mln Vs Net Loss $4.1 Mln Last Year
8/31/2020 7:09:21 AM
Akari Therapeutics Announces Intl Clinical Development Program Of Nomacopan For COVID-19 Pneumonia
7/1/2020 11:15:42 AM
Akari Therapeutics Appoints Torsten Hombeck As CFO
7/1/2020 9:17:38 AM
Akari Therapeutics Appoints Torsten Hombeck CFO
5/12/2017 6:47:50 AM
William Blair Downgrades Akari Therapeutics Plc (AKTX) To Market Perform From Outperform
4/6/2017 7:11:21 AM
William Blair Initiates Akari Therapeutics Plc (AKTX) At Outperform